Oxford BioTherapeutics' Debt Round

Oxford BioTherapeutics raised a round of funding on July 30, 2015. Investors include Silicon Valley Bank.

Oxford BioTherapeutics is an international, clinical-stage biotechnology company focused on developing antibody-based therapies to treat cancer. Combining immuno-oncology, antibody-drug conjugates, an…

Articles about Oxford BioTherapeutics' Debt Round: